Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
Background: Prior studies suggest similar long-term mortality rates for patients with heart failure (HF) with preserved ejection fraction (HFpEF) vs reduced ejection fraction. However, although coronary heart disease (CHD) is associated with worse prognosis in HF, clinical outcomes are less well cha...
Guardado en:
Autores principales: | Nancy Luo, MD, MHS, Christopher M. O'Connor, MD, Karen Chiswell, PhD, Kevin J. Anstrom, PhD, L. Kristin Newby, MD, MHS, Robert J. Mentz, MD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6738d01874e04caa85a41cfa1501d83c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Automated Measurements of Left Ventricular Ejection Fraction and Volumes Using the EchoPAC System
por: Xiaoxue Chen, MD, Shaoling Yang, PhD, Qianqian He, MD, Yin Wang, PhD, Linyan Fan, MD, Fengling Wang, MD, Kun Zhao, MD, Jing Hu, MD
Publicado: (2021) -
Short QT interval as a harbinger of an arrhythmogenic cardiomyopathy
por: Philippe Chevalier, MD, PhD, et al.
Publicado: (2021) -
Organoid vs In Vivo Mouse Model: Which is Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Shinya Sugimoto, MD, PhD, et al.
Publicado: (2022) -
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Katsuhiro Yoshimura, MD, PhD, et al.
Publicado: (2021) -
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
por: Kei Kunimasa, MD, PhD, et al.
Publicado: (2021)